Francesco Rodeghiero

Vicenza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 136 publications

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Journal: American journal of hematology

Published: March 09, 2026

Introduction to the Review Series. A century after Erik von Willebrand.

Introduction to the Review Series. A century after Erik von Willebrand.

Journal: Haematologica

Published: December 11, 2025

Splenectomy: still a life-saving treatment in immune thrombocytopenia.

Splenectomy: still a life-saving treatment in immune thrombocytopenia.

Journal: Haematologica

Published: July 01, 2025

Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries.

Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries.

Journal: Haematologica

Published: January 27, 2025

Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype.

Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype.

Journal: HemaSphere

Published: September 10, 2024

Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

Journal: American journal of hematology

Published: April 11, 2024

Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.

Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.

Journal: Blood advances

Published: June 20, 2023

Correction: Recent progress in ITP treatment.

Correction: Recent progress in ITP treatment.

Journal: International journal of hematology

Published: May 30, 2023

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: May 05, 2023

Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.

Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.

Journal: Mediterranean journal of hematology and infectious diseases

Published: December 22, 2022

Recent progress in ITP treatment.

Recent progress in ITP treatment.

Journal: International journal of hematology

Published: November 28, 2022

Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion.

Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion.

Journal: Therapeutic advances in hematology

Published: September 11, 2022

Showing 1-12 of 136

Last Updated: 09/26/2026